Prognostic factors in choroidal and ciliary body melanomas with extrascleral extension
- PMID: 3953727
- DOI: 10.1016/0002-9394(86)90828-7
Prognostic factors in choroidal and ciliary body melanomas with extrascleral extension
Abstract
In a retrospective study, 50 (8.2%) of 610 patients with malignant melanoma of the ciliary body or choroid had extrascleral extension. Of 46 patients for whom follow-up data were available, 24 (52%) survived five years, 20 (42%) survived ten years, and 17 (37%) survived 15 years. Factors that seemed to affect survival significantly included intraocular tumor size and extraocular tumor size and location. Our observations did not support the role of primary exenteration. Five patients (11%) with extrascleral extension had orbital recurrences and all died within 31 months of surgery regardless of treatment.
Similar articles
-
Plaque radiotherapy for choroidal and ciliochoroidal melanomas with limited nodular extrascleral extension.Can J Ophthalmol. 2004 Jun;39(4):380-7. doi: 10.1016/s0008-4182(04)80009-7. Can J Ophthalmol. 2004. PMID: 15327103
-
Plaque radiotherapy for management of ciliary body and choroidal melanoma with extraocular extension.Am J Ophthalmol. 2000 Jul;130(1):97-102. doi: 10.1016/s0002-9394(00)00385-8. Am J Ophthalmol. 2000. PMID: 11004266
-
Orbital extension of Choroidal and ciliary body melanomas.Arch Ophthalmol. 1977 Nov;95(11):2002-5. doi: 10.1001/archopht.1977.04450110096010. Arch Ophthalmol. 1977. PMID: 921579
-
[A case of exteriorized malignant ciliochoroidal melanoma in a negroid patient].J Fr Ophtalmol. 1989;12(3):236-8. J Fr Ophtalmol. 1989. PMID: 2695562 Review. French. No abstract available.
-
[Preoperative irradiation before enucleation in malignant melanoma of the uvea. Review of the literature and initial personal experiences].Klin Monbl Augenheilkd. 1989 Apr;194(4):252-60. doi: 10.1055/s-2008-1046367. Klin Monbl Augenheilkd. 1989. PMID: 2657203 Review. German.
Cited by
-
Enucleation combined with orbital implants for malignant melanoma of the uvea.Int Ophthalmol. 1989 Jul;13(4):243-51. doi: 10.1007/BF02280083. Int Ophthalmol. 1989. PMID: 2613446
-
Current molecular and clinical insights into uveal melanoma (Review).Int J Oncol. 2021 Apr;58(4):10. doi: 10.3892/ijo.2021.5190. Epub 2021 Mar 2. Int J Oncol. 2021. PMID: 33649778 Free PMC article. Review.
-
Orbital exenteration: a 13 year Manchester experience.Br J Ophthalmol. 2005 Oct;89(10):1335-40. doi: 10.1136/bjo.2004.062471. Br J Ophthalmol. 2005. PMID: 16170127 Free PMC article.
-
Factors related to survival outcomes following orbital exenteration: a retrospective, comparative, case series.BMC Ophthalmol. 2018 Jul 28;18(1):186. doi: 10.1186/s12886-018-0850-y. BMC Ophthalmol. 2018. PMID: 30055580 Free PMC article.
-
DNA ploidy and S-phase fraction as prognostic factors in patients with uveal melanomas.Br J Cancer. 1995 Jan;71(1):177-81. doi: 10.1038/bjc.1995.36. Br J Cancer. 1995. PMID: 7819036 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical